BioSpace spoke with Paula Ragan, CEO and President of X4 Pharmaceuticals, a company focused on restoring healthy immune system function in people with rare diseases.
BioSpace spoke with Paula Ragan, CEO and President of X4 Pharmaceuticals, a company focused on restoring healthy immune system function in people with rare diseases.
Gene therapy, stem cell therapy, CAR T, cell therapy, and gene editing are all forms of genomic medicine1 – an approach to cure and treat human diseases that uses human biology rather than chemical compounds made in the lab.
The COVID-19 pandemic is far from over, yet with vaccination programs well underway and an end to rising infections in sight, we now have the opportunity to assess…
The ability to consistently bring treatments and cures to market depends upon a company’s capacity to create and sustain a successful product development pipeline.
Written for and originally published on AGT Big Picture Gene therapy, stem cell therapy, CAR-T, cell therapy and gene editing […]
Sanjeev Luther, CEO and Board Member of Rafael Pharmaceuticals, pictured above. BioSpace recently spoke with Sanjeev Luther, CEO and board […]